Summary
25 / 100 · Bulios Score
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
Revenue grew by 6.9% a year over 5 years. Over the last 3 years it grew by 4.5% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $2.73M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 187.1 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2021By product
- Sales-based software bundle revenue 100%
By region
The company reports no revenue by region.
Sales-based software bundle revenue brings in 100% of revenue.
Segments in detail